Stockreport

Verve falls after early-stage data for lead asset [Seeking Alpha]

Beam Therapeutics Inc.  (BEAM) 
PDF VERVE-101 from patients with a form of dyslipidemia called heterozygous familial hypercholesterolemia (HeFH). Citing a data cut of 10 patients on October 16, Verve ( V [Read more]